In the Race to Combat Climate Change, C.H. Robinson Sees 654% Increase in Renewables Business While the Booming Clean Energy Sector Faces Five Key Logistics Challenges
At a time when world leaders are setting aggressive goals to fight climate change, global logistics company C.H. Robinson is realizing triple-digit growth in its renewable-energy logistics business and helping the renewables industry cope with five key challenges. Feeding the demand for wind and solar power depends not only on overcoming today’s global supply-chain disruptions, but also reducing the risks, damages, complexities and costs inherent to projects that stretch into some of the most remote places on Earth.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210624005350/en/
C.H. Robinson helps renewable-energy companies manage the supply chain and logistics for complex projects in some of the most remote places on Earth. (Photo: Business Wire)
C.H. Robinson, which manages renewable-energy transportation and logistics from manufacturing to installation to recycling, has seen its renewables business soar 654% globally in just the past three years. This work will create 14,000 megawatts of energy – enough solar energy to charge 1.73 million electric cars and enough wind energy to power a city the size of London for four months.
Growth in renewables is being fueled by the 194 nations of the Paris climate accord pledging to reduce greenhouse gases, tech advances lowering the cost of renewables compared to fossil fuels, and utilities and the business community investing more in clean energy sources. Tax incentives in the United States have also attracted new investors. The recent extension of those tax credits and the Biden administration proposing $2 trillion in climate-related spending are likely to propel the U.S. market for the next few years. Globally, investment in the sector is expected to grow sevenfold, reaching $2.15 trillion in 2025.
“The stakes are too high for these complex projects not to succeed,” said Mike Short, C.H. Robinson’s President of Global Forwarding. “The gap between sustainability goals and enough renewable energy to meet those goals can only be filled with a viable supply chain. That supply chain stretches across continents, from mines to manufacturing plants to some of the most remote places on Earth. Wind farms are being built in the ocean. Solar farms with millions of panels are rising in the desert. Just to make a solar panel, roughly 40 different components need to get to the factory, including precious metals. These projects are built on tight timelines and budgets, and companies risk millions in unexpected costs if there are delays anywhere along the way.”
Five supply-chain barriers pose the biggest threats to keeping up with the world’s demand for green energy:
- Special equipment needs: Wind turbines keep getting bigger, with some as tall as an 85-story building. The sweep of the blades is more than an acre. Moving oversized parts requires both special expertise and equipment, including flatbed trucks that are in exceptionally short supply. This year has seen load-to-truck ratios over 100:1, meaning 100 loads waiting to be delivered for every flatbed truck available. Solar equipment, on the other hand, has sensitive electronics and glass easily subject to damage, and is also competing for transportation capacity amid one of the tightest markets in history.
- Unpredictability: Five years ago, the movement of goods such as solar panels out of Asia was high volume, low cost. Now, ship capacity is scarce and more expensive because of fewer shipping lines and a global container shortage. Port congestion makes it harder to know when your vessel will arrive, when freight will be unloaded or when enough truck chassis will be available to move it.
- Global supply chain visibility: If 45 containers a day need to arrive at a project site from different origins, knowing each load’s location at any time is critical for contingency planning, timeline management, cost mitigation, and decision-making such as whether 25 or 75 workers are needed at an installation site on any given day. Without centralized visibility and management, blind spots fuel more unpredictability and projects become subject to disparate processes across multiple vendors.
- Tighter budgets: Rising costs– from polysilicon used in solar panels to aluminum to freight charges – are adding pressure to the profitability of projects. Unexpected costs when projects don’t go as planned, like parts arriving late or damaged, can then erase profit margins. Fines are a constant threat.
- Strict timelines: Because developers and investors are hurrying to get projects started in order to meet the deadlines for tax credits, they build in contract penalties that can add up to six or seven figures for parts or equipment delivered late. Also, the nature of these vast, one-time projects makes them vulnerable to lack of resources and infrastructure to meet their needs quickly enough, especially in remote areas.
Renewable-energy companies and investors rely on C.H. Robinson not just to manage transportation, but also to provide the planning, project management, customs expertise, warehousing and on-site logistics to get clean energy projects off the ground.
“NextEnergy Capital has built, owns and operates more than 1.5 gigawatts of solar electric power plants across the world,” said Filinto Martin, Managing Director of NPIII, a NextEnergy Capital fund. “We recently had nearly 200 containers of solar panels arriving to the East Coast of the United States from Asia, with the equipment destined for two different sites. We entrusted C.H. Robinson to find local warehousing and track the inventory until the project sites were ready.”
C.H. Robinson has also helped
- A renewable-energy developer get 2,000 acres of solar panels delivered on time and on budget for a global beverage company to fulfill a sustainability pledge
- A manufacturer lower its damaged shipments to 1% and raise on-time delivery to 99%
- A manufacturer avoid penalties of up to $10,000 per load per day
“These companies cannot afford any black holes in the process, especially during one of the most volatile markets in history,” said C.H. Robinson renewables expert Jim Mancini, the vice president who oversees the company's services and technology for the energy sector. “That’s why we work to anticipate every contingency and offer visibility through our single, global multimodal technology platform, Navisphere. To keep these complex projects on track, it’s crucial to ensure that parts are where they need to be, the right transportation and specialized equipment are available, and the finished product arrives to the project site when on-the-ground teams are ready to receive and install. We are proud to leverage our scale and global suite of services to help renewable-energy companies protect and preserve our planet.”
About C.H. Robinson
C.H. Robinson solves logistics problems for companies across the globe and across industries, from the simple to the most complex. With $21 billion in freight under management and 19 million shipments annually, we are one of the world’s largest logistics platforms. Our global suite of services accelerates trade to seamlessly deliver the products and goods that drive the world’s economy. With the combination of our multi-modal transportation management system and expertise, we use our information advantage to deliver smarter solutions for our more than 105,000 customers and 73,000 contract carriers. Our technology is built by and for supply chain experts to bring faster, more meaningful improvements to our customers’ businesses. As a responsible global citizen, we are also proud to contribute millions of dollars to support causes that matter to our company, our Foundation and our employees. For more information, visit chrobinson.com (Nasdaq: CHRW).
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210624005350/en/
Contact information
Kelsey Soby, kelsey.soby@chrobinson.com
Kaelan Richards, krichards@bpimedia.com, 617-777-3883
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Lone Star Announces Sale of Xella to Holcim20.10.2025 07:40:00 EEST | Press release
Lone Star Funds (“Lone Star”) today announced the signing by an affiliate of Lone Star Fund X, LP of a binding agreement to sell Xella Group (“Xella”), a leading provider of walling solutions, to Holcim, the leading partner for sustainable construction. The transaction values Xella at approximately €1.85 billion. Headquartered in Duisburg, Germany, Xella is a European provider of efficient and sustainable walling solutions for the entire house shell, operating brands such as Ytong, Silka, Hebel and Multipor. The company employs more than 4,000 team members. In partnership with Lone Star, Xella has taken significant strides in recent years to optimize its offering by strategically focusing the business on walling solutions, while also enhancing its commercial and digital capabilities. Under Lone Star’s stewardship, Xella has also continued to progress its sustainability initiatives. Today, the business stands as a market leader in its sector with a strong reputation for a people-first c
Worldwide First: Biedermann Motech Further Expands its MOSS!MODULARITY Platform and Announces Introduction of Multiple New Products20.10.2025 07:00:00 EEST | Press release
Biedermann Motech, the prominent innovator in next generation spinal and extremity implant systems and procedural solutions, today announced the market introduction of several additions to its MOSS!MODULARITY™ platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251019799867/en/ MOSS!MODULARITY Injection Screw MOSS!MODULARITY encompasses a broad range of products and technologies for spinal surgery based around the concept of providing an advanced modular workflow for posterior stabilization and deformity correction. The modular workflow allows surgeons to place the headless bone screw shafts as a first step, without the tulip heads attached, and offers several advantages over working with traditional pre-assembled pedicle screws, e.g.: Improved visualisation and access to the surgical working space; Precise decompression, decortication and osteotomies without any interference with polyaxial tulip heads; Increased surgic
Incyte Announces Phase 1 Results for its TGFβR2×PD-1 Bispecific Antibody in Advanced Colorectal Cancer and KRAS G12D Inhibitor in Advanced Pancreatic Ductal Adenocarcinoma19.10.2025 20:30:00 EEST | Press release
Incyte (Nasdaq:INCY) announced the first clinical data evaluating its TGFβR2×PD-1 bispecific antibody (INCA33890) for patients with microsatellite stable (MSS) colorectal cancer; and its potent, selective and orally bioavailable KRAS G12D inhibitor (INCB161734) for patients with KRAS G12D mutations, specifically pancreatic ductal adenocarcinoma (PDAC). The data were featured in two oral sessions (Investigational immunotherapy; Abstract #1522MO and Developmental therapeutics; Abstract #916O, respectively) at the European Society of Medical Oncology (ESMO) Congress 2025. “The proof-of-concept data highlight the potential of INCA33890 and INCB161734 to address significant medical needs in patients with advanced solid tumors, including MSS colorectal cancer and PDAC,” said Pablo J. Cagnoni, M.D., President and Head of Research and Development, Incyte. “These results, including the favorable safety profiles as monotherapies, support continued clinical development. We look forward to explori
Corcept Presents ESMO 2025 Late-Breaker: Relacorilant Demonstrates Benefit in Patients with Platinum-Resistant Ovarian Cancer with Prior PARP Inhibitor Treatment19.10.2025 12:15:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today shared new late-breaking data from its pivotal Phase 3 ROSELLA trial of relacorilant plus nab-paclitaxel in patients with platinum-resistant ovarian cancer at the European Society for Medical Oncology (ESMO) 2025 Annual Meeting. The data demonstrated a progression-free survival (PFS) benefit for patients who experienced disease progression while on or after taking a PARP inhibitor (PARPi), a patient population with particularly poor prognosis. The presentation slides can be found here. The company also announced expansion of the Phase 2 BELLA trial in a poster session at ESMO, found here. New relacorilant data presented at ESMO demonstrated a consistent benefit in PARPi subgroups to overcome chemotherapy resistance. Relaco
Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA ™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 202518.10.2025 14:00:00 EEST | Press release
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the two-year efficacy and safety results from its MOTION Phase 3 study of vimseltinib in patients with TGCT in cases where surgical removal of the tumor is not an option will be presented as a poster during the 2025 European Society for Medical Oncology Congress (ESMO), taking place October 17-21 in Berlin, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251018921529/en/ “These long-term Phase 3 MOTION results add to the established body of evidence supporting vimseltinib as a best-in-class treatment for TGCT,” said Matthew L. Sherman, M.D., Chief Medical Officer of Deciphera. “TGCT often causes debilitating pain, stiffness and impaired mobility and these results demonstrate the durable benefit that vimseltinib can offer patients.” Summary of Data and Findings from the 2-year results of the MOTION Phase
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom